Karl H Plate
Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model
Osterberg N, Plate K, Schaefer H, Doostkam S, Weyerbrock A, Niedermann G, Gaedicke S, Vacher J, Ferrara N, Machein M. Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model. Neuro-oncology 2016; 18:939-49.
06.03.2016Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model
06.03.2016Neuro-oncology 2016; 18:939-49
Osterberg Nadja, Plate Karl H, Schaefer Hans-Eckart, Doostkam Soroush, Weyerbrock Astrid, Niedermann Gabriele, Gaedicke Simone, Vacher Jean, Ferrara Napoleone, Machein Marcia Regina
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
Scholz A, Meinhardt M, Weyerbrock A, Timmer M, Goldbrunner R, Deckert M, Braun C, Schittenhelm J, Frueh J, Ullrich E, Mittelbronn M, Plate K, Krex D, Herrlinger U, Glas M, Harter P, Cremer S, Yalcin B, Gurnik S, Yamaji M, Di Tacchio M, Sommer K, Baumgarten P, Bähr O, Steinbach J, Trojan J, Reiss Y. Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol Med 2015; 8:39-57.
14.12.2015Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
14.12.2015EMBO Mol Med 2015; 8:39-57
Scholz Alexander, Meinhardt Matthias, Weyerbrock Astrid, Timmer Marco, Goldbrunner Roland, Deckert Martina, Braun Christian, Schittenhelm Jens, Frueh Jochen T, Ullrich Evelyn, Mittelbronn Michel, Plate Karl H, Krex Dietmar, Herrlinger Ulrich, Glas Martin, Harter Patrick N, Cremer Sebastian, Yalcin Burak H, Gurnik Stefanie, Yamaji Maiko, Di Tacchio Mariangela, Sommer Kathleen, Baumgarten Peter, Bähr Oliver, Steinbach Joachim P, Trojan Jörg, Reiss Yvonne